OP
APTO

ORG Partners’s Aptose Biosciences, Inc. APTO Stock Holding History

ORG Partners’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-133
Closed -$2.98K – 1412
2024
Q2 		$2.98K Buy
+133
New +$4.51K ﹤0.01% 1466

Other funds holding APTO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

ORG Partners's APTO Position: Q3 2024 in Review

ORG Partners sold out of Aptose Biosciences, Inc. (APTO) in Q3 2024, closing a stake of 133 shares — an estimated $2.98K sold.

ORG Partners first reported a position in APTO in Q2 2024 and held it in 1 quarter. The position peaked at $2.98K in Q2 2024. 23 funds tracked by Wall St. Rank hold APTO as of Q3 2024.

  • ORG Partners reported no remaining Aptose Biosciences, Inc. position as of Q3 2024 after selling out during the quarter.
  • ORG Partners sold 133 Aptose Biosciences, Inc. shares in Q3 2024, an estimated $2.98K.
  • ORG Partners first reported a position in Aptose Biosciences, Inc. in Q2 2024 and held it in 1 quarter.
  • ORG Partners's Aptose Biosciences, Inc. position peaked at $2.98K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2024.

Based on ORG Partners's 13F filing for Q3 2024, filed 11 Oct 2024.